Cyclarity Therapeutics Email Format

Biotechnology ResearchCalifornia, United States11-50 Employees

Cyclarity Therapeutics is a biotechnology company focused on addressing the underlying causes of age-related disease. It develops interventions aimed at toxic forms of cholesterol, using engineered molecules to pursue disease-modifying therapies for age-related conditions such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration.

Based in Novato, California, Cyclarity is a small biotechnology company focused on translational science within the biotechnology research sector. During May 2026, the company presented human data at the American Heart Association Vascular Discovery Scientific Sessions describing the safe excretion of 7-ketocholesterol, a toxic oxidized cholesterol linked to arterial plaque buildup.

Sign up for free to view info

Company overview Employee directory